Relationship between pancreatic cancer and intestinal microbiota

Characteristics and Role of Intestinal Microbiota in Pancreatic Cancer Incidence and Chemotherapy Effectiveness

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030240554

Enrollment

120

Registered

2024-12-16

Start date

2024-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who are 40 years of age or older at the time consent is obtained 2) Patients who have been diagnosed with pancreatic cancer and are scheduled to receive chemotherapy. 3) Patients who have received a thorough explanation of their participation in this study, and who have given written consent of their own free will based on sufficient understanding.

Exclusion criteria

Exclusion criteria: 1) Patients deemed inappropriate as research subjects by the principal investigator 2) Patients who have refused to participate in this study

Design outcomes

Primary

Measure	Time frame
Characteristic intestinal microbiota in patients with pancreatic cancer	—

Secondary

Measure	Time frame
Relationship between changes in gut microbiota before and after pancreatic cancer chemotherapy and chemotherapy efficacy Relationship between changes in gut microbiota before and after chemotherapy for pancreatic cancer and side effect profile Relationship between gut microbiota before and after chemotherapy for pancreatic cancer and prognosis	—

Contacts

Public ContactKei Saito

Nihon University School of Medicine

saito.kei@nihon-u.ac.jp+81-3-3972-8111

Outcome results